| What is RSS feed? | About Us |
 |
 Search Score: 4/10
Source: www.marketwatch.com --- 36 days ago
SAN FRANCISCO (MarketWatch) -- Express Scripts Inc. said late Wednesday that its second-quarter profit rose to $190.2 million, or 75 cents a share, from $152.7 million, or 57 cents a share, in the year-ago period. The company said earnings from continuing operations were 76 cents a share for the latest quarter. Revenue rose to $4.71 billion from $4.57 billion last year. Analysts surveyed by FactSet Research estimated a quarterly profit of 72 cents a share on revenue of $4.75 billion. The company sees 2008 adjusted earnings of $3.03 to $3.10 a share. Analysts expect $3 a share. ... Source: www.medicalnewstoday.com --- 36 days ago
Cigna and Express Scripts have agreed to a $27 million settlement in a 2004 lawsuit by New York State accusing Express Scripts of persuading physicians to switch prescriptions to drugs for which larger rebates could be obtained from manufacturers without informing patients of the change, the ... Source: seekingalpha.com --- 19 days ago
Michael Filloon submits: With all the talk of the crash of commodities and resurgence of the US dollar, it is easy to forget key growth companies that have held up well in this volatile environment. As investors flood into many of the financials, it has been easy to forget some of the new healthcare companies. Healthcare changes have been sweeping through as Medicare continues to cut reimbursement. These cuts place pressure on companies to lower costs as they see their margins cut. Pharmacy benefits managers seem well placed going forward. Not only has this group shown resiliance in a tough market environment, but they have also shown the ability to increase margins, even in the face of decreasing revenue. Complete Story » ... Source: www.lexisnexis.com --- 4 days ago
Case name: People of the State of New York, by Andrew M. Cuomo, Attorney General of the State of New York, et al. v. Express Scripts Inc., et al.; See 8/18/04, Page 4. Full story on lexis.com ... Source: www.primenewswire.com --- 3 days ago
ST. LOUIS, Sept. 3, 2008 (GLOBE NEWSWIRE) -- Express Scripts, Inc. (Nasdaq:ESRX) announced that it will present at the Bank of America 38th Annual Investment Conference on September 15, 2008 at 2:00 p.m. pacific (5:00 p.m. eastern) at Ritz-Carlton Hotel in San Francisco, CA. ... Source: www.streetinsider.com --- 33 days ago
Visit StreetInsider.com at http://www.streetinsider.com/Downgrades/Broadpoint+Downgrades+Express+Scripts+%28ESRX%29+to+Buy/3872581.html for the full story. ... Source: www.topix.com --- 29 days ago
The symmetrical triangle is one of the most commonly used chart patterns by active traders. ... Source: www.topix.com --- 33 days ago
Revenue was up just 2.9% for the quarter, but it's the various profit lines that investors should really care about. ... Source: patientadvocate.wordpress.com --- 20 days ago
My old boss and someone for whom I have great personal and professional respect is Steve Miller, MD who is the Chief Medical Officer at Express Scripts. I still remember the day I heard he was coming to the company and desperately trying to Google him to find out something about him. I [...] ... Source: www.topix.com --- 33 days ago
Express Scripts Inc. and CIGNA Corp. have settled a lawsuit brought by New York state that accused the pharmacy benefit manager of inflating prescription drug costs for the state's largest employee health plan. ... Source: www.topix.com --- 35 days ago
Express Scripts Inc. and CIGNA are paying a total of $27 million to settle a 2004 lawsuit by the state of New York that accused Express Scripts of getting doctors to switch patients' drugs and pocketing rebates ... ... Source: www.topix.com --- 36 days ago
Express Scripts Inc ., the third- largest U.S. manager of drug benefits, said profit rose 25 percent as increased use of generic medicines lowered the cost of customer claims. ... Source: news.yahoo.com --- 31 days ago
Express Scripts, a prescription drug provider, is closing its Albuquerque Contact Center, leaving 159 people without jobs. ...
Source: www.lexisnexis.com --- 4 days ago
ST. LOUIS - A pharmacy benefits manager (PBM) was not an Employee Retirement Income Security Act fiduciary when it took actions related to pricing drugs and negotiating for rebates but was a fiduciary in controlling and disposing of formulary savings, a federal judge in Missouri ruled July 30 (In re Express Scripts, Inc., PBM Litigation [Minshew, et al. v. Express Scripts, Inc.; Brown, et al. v. Express Scripts, Inc.], Master No. 4:05-MD-01672, E.D. Mo. [No. 4:02-CV-01503, D. Mo.; No. 3:04-01822, D. Conn.]; See 4/5/06, Page 6). Full story on lexis.com ... Source: www.bloggingstocks.com --- 17 days ago
Filed under: Caremark Rx (CMX) , CVS Corp (CVS) Investors are used to receiving conflicting ideas about what to do with their money, but at the exact same minute, Marketwatch reported two different ideas for Caremark RX, Inc. (NYSE: CMX) shareholders. At 1:58 PM, Michael Baron reported that Express Scripts urges Caremark shareholders to nix CVS deal . After that, or perhaps immediately before, I don't really know, Katherine Hunt reported that CVS urges Caremark shareholders to vote for merger . CVS Corp. (NYSE: CVS )pointed to the "conditionality and risk" inherent in Express Scripts' offer. Express Scripts (NSADAQ: ESRX ) said that "If we discover additional value during due diligence, it is only logical that we could increase our offer." I don't know about you, but these takeover battles are the most exciting part of following the market. I'll be continuing to follow this one closely. Permalink | Email this | Linking Blogs | Comments ...
Source: www.bloggingstocks.com --- 17 days ago
Filed under: Other issues , Deals , Management , Competitive strategy , Caremark Rx (CMX) , CVS Corp (CVS) At long last, the CVS (NYSE: CVS ), Caremark Rx (NYSE: CMX), Express Scripts (NASDAQ: ESRX ) menage-a-trois has been settled. CVS will acquire Caremark Rx for $26.5 billion. Bidding for Caremark Rx by both Express Scripts and CVS has been going on in public for several months. Due to pressure from Express Scripts, which had sought to acquire Caremark Rx to form a huge pharmacy-benefits management company, CVS will pay a hefty premium after sweetening the deal on three separate occasions to beat back acquisition overtures from Express Scripts. Up to the proverbial last minute, Express Scripts insisted it would meet or exceed any CVS offer if only Caremark Rx would be more forthcoming with company information. According to Dinah Brin of The Wall Street Journal , Express Scripts had offered 0.426 of its own shares plus $29.95 in cash for each Caremark share. It also agreed to a penny per share daily fee during the closing period. Federal antitrust regulators had concerns about this deal, which again opened the door for another offer by CVS. CVS will pay 1.67 of its own shares plus $7.50 in cash for each Caremark share. CVS shareholders will own 54.5% of the new company, while Caremark Rx shareholders will own 45.5 %. CVS had argued in print that the Express Scripts' proposal would create a company that was so highly leveraged it woul ... Source: www.fiercehealthcare.com --- 35 days ago
While last quarter was pretty much a gloom and doom situation for health plans, this quarter is shaping up better for the industry. Yesterday, we noted that Aetna's second-quarter profits had grown a respectable 10 percent . Now the story is Cigna, whose Q2 '08 income climbed a more-impressive 37 percent over the same period last year. Its net income was $272 million for the second quarter, up from $198 million one year ago. Revenue, meanwhile, rose 11 percent to $4.86 billion from $4.38 billion. Cigna's income growth came from several sources, including a 19 percent growth in medical membership over the first half of the year, and premium fees climbed 13 percent. Both were fueled partly by the company's April 1 acquisition of Great-West Healthcare. Part of the reason it's doing well financially is that it has less exposure to the commercial risk market than some of its competitors, as it offers fixed-fee products like disability and life insurance. In its health sector, the company offers not only medical coverage, but also behavioral, dental, disease management and pharmacy-related products and services. To learn more about Cigna's results: - read this Cigna press release - read this Wall Street Journal piece (sub. req.) Related Articles: Aetna profits up on member, premium increases Cigna rolls out Second Life community Cigna first-quarter profits drop 80 percent Express Scripts, Cigna agree to $27M 'drug switching' settlement ... Find more results for Express Scripts on RSSMicro.com |
Related Content |
Copyright © 2008 RSSMicro.com
I managed hundreds of Red Hat, Fedora, and CentOS servers between 1998 and 2006. That’s over 8 years of using the service command to start, stop, restart, and obtain the status of the many services located in /etc/init.d . After my migration to Ubuntu, I would often find myself trying to use the service command at an Ubuntu command prompt. With some digging, I might have found two different implementations in Ubuntu, trying to provide the service command’s functionality, in the packages: sysvconfig debian-helper-Scripts However, neither of these implementations were very good or complete. After taking an overnight flight to London, Rick Clark and I were on the Gatwick Express heading into Canonical’s office in London. We decided that the Ubuntu Server would very much benefit from a clean implementation of the traditional Red Hat service command, installed by default. And thus, /usr/bin/service is now provided by sysvinit-utils (2.86.ds1-59ubuntu4) in Intrepid. This provides a convenient wrapper for running things like: service apache2 restart And it also provides a comprehensive mechanism for gathering the status of all services on the system: service –status-all Which, at the moment, exposes how many init Scripts we have that are lacking status actions. If you would like to help with that, please see: http://dustinkirkland.wordpress.com/2008/08/03/adding-a-status-action-to-init-Scripts/ :-Dustin ...
Filed under: Deals , Good news , Caremark Rx (CMX) , CVS Corp (CVS) , Options , Technical Analysis CVS Corp. (NYSE: CVS ) opened at $31.90. So far today the stock has hit a low of $31.81 and a high of $32.28. As of 12:40 this afternoon, CVS is trading at $32.03, up $0.71 (2.3%). Shares have recovered a bit over the past few months, showing support around $31. Though rival Express Scripts (NASDAQ: ESRX ) has increased its offer for the hostile takeover of Caremark Rx (NYSE: CMX ), CVS officials say that the CVS buyout offer will likely prevail due to antitrust concerns regarding the Express Scripts offer. The technical indicators for CVS have been bullish but deteriorating, while S&P gives the stock a very positive 5 STARS (out of 5) strong buy rating. For a bullish hedged play on this stock, I would consider a May bull-put credit spread below the $27.50 range. CVS hasn't been below $27.50 in the past year except for a few days in November and has shown support around $30.75. This trade could be risky depending on what happens with the CMX-ESRX-CVS mess, but even if CVS pulls back some, this position could be protected by the strong support just below $28. Brent Archer is an options analyst and writer at Investors Observer (Free Subscription). DISCLOSURE: Mr. Archer owns and/or controls diversified portfolios of long and short stock and option positions that may include holdings in companies he writes about. Permalink | Email this ....gif){kind=logo}
Filed under: Deals , Caremark Rx (CMX) , CVS Corp (CVS) Express Scripts Inc (NASDAQ: ESRX ) upped its offer for Caremark RX Inc (NYSE: CMX ) last night. Express, a pure pharmaceutical benefits management company, or PBM, is in a battle with CVS Corporation (NYSE: CVS ), the pharmacy chain, over Caremark. Express supposedly raised its offer over concerns that it will soon receive a second request from regulators. This would most likely mean the deal would not close for another six to nine months. CVS and Caremark have already received regulatory approval with the shareholder vote coming in a few weeks. This is a bizarre transaction in that a PBM like Caremark has never merged with a pharmacy chain like a CVS. Shareholders believe Caremark management and board is acting in their own best interests rather than the interest of shareholders. Actually, there are few sell-side analysts or shareholders who know the industry well who actually see the business merits of the two companies merging. Meanwhile, as this battle unfolds, it appears the fundamentals for this industry are improving. Medco and Express both reported very strong results and guided to strong results. Express' management is very well-respected and most believe would do a very good job working with Caremark. The battle is set for the shareholders' meeting set in the next few weeks. We will see if Express increases their offer again prior to the shareholder meeting. Permalin ...